{"filing":{"accession_number":"0001493152-26-036109","cik":"0001853816","ticker":"DRMAW","company_name":"Dermata Therapeutics, Inc.","form":"8-K","filing_date":"2026-08-05","report_date":"2026-08-05","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1853816/000149315226036109/form8-k.htm"},"events":[{"id":24879,"run_id":22554,"accession_number":"0001493152-26-036109","anchor_item_number":null,"event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"summary":"The filing discloses Dermata's anticipated launch date for its first commercial product, Tome Foundational Treatment, scheduled for August 25, 2026, with pricing and distribution details. This represents a material operational and strategic milestone—the company's shift from development to commercialization of a consumer skincare product. While not a traditional M\u0026A, earnings release, or governance event, this product launch is a significant operational event that would affect a reasonable investor's assessment of the company's business trajectory and revenue prospects.","company_name":"Dermata Therapeutics, Inc.","ticker":"DRMAW","filing_date":"2026-08-05","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":25571,"accession_number":"0001493152-26-036109","item_number":null,"item_title":null,"event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"reasoning":"The filing discloses Dermata's anticipated launch date for its first commercial product, Tome Foundational Treatment, scheduled for August 25, 2026, with pricing and distribution details. This represents a material operational and strategic milestone—the company's shift from development to commercialization of a consumer skincare product. While not a traditional M\u0026A, earnings release, or governance event, this product launch is a significant operational event that would affect a reasonable investor's assessment of the company's business trajectory and revenue prospects.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-07T02:32:20.863788+00:00","company_name":"Dermata Therapeutics, Inc.","ticker":"DRMAW","filing_date":"2026-08-05"}]}